Warning: The magic method WPEX_Image_Resize::__wakeup() must have public visibility in /customers/8/c/4/alpshpbmeeting.org/httpd.www/wp-content/themes/Total/framework/classes/image-resize.php on line 34 Poster / Free Paper Sessions – ALPS skip to Main Content
FREE PAPERS
TIME No. Presentation Title Presenter
09.15 – 09.20 FP01 Combined portal vein and hepatic occlusion in regenerative liver surgery: a comprehensive multi-institutional analysis of the current world experience Franziska Heid
18.25 – 18.30 FP02 Early anastomotic biliary complications after liver transplantation; do they matter? Samuel Tingle
18.30 – 18.35 FP03 Short-term outcomes after total pancreatectomy: a European prospective modified-snapshot study Anouk Latenstein
E-POSTERS SCREEN 1
16.30 – 17.00 AB01 Feasibility of a prehabilitation clinic for patients undergoing oncologic abdominal surgery: the first results Willemijn van der Plas
AB02 Impact and risk factors for clinically relevant surgery-related muscle loss in patients after major abdominal cancer surgery: study protocol and preliminary results from a prospective observational cohort study (MUSCLE POWER) Willemijn van der Plas
AB03 Sarcopenia by CT scan correlated with reduced kinetic growth of livers after portal vein embolisation Jan Heil
AB04 High intensity focused ultrasound for pancreatic cancer Keaton Jones
SCREEN 2
AB05 Retrospective observational study of patient outcomes with local wound infusion vs epidural analgesia after major hepato-pancreato-biliary surgery. Alexandra Jackson
AB06 Impact of ERAS protocol with early oral feeding following pancreatic Whipple’s procedure Leigh Cui
AB07 Real-time surgical margin assessment using ICG-fluorescence during laparoscopic and robot-assisted resections of colorectal liver metastases Friso Achterberg
AB08 Evaluating biomarkers for tumour-specific imaging of colorectal liver metastases Friso Achterberg
FREE PAPERS
TIME No. Presentation Title Presenter
09.40 – 09.45 FP04 Myosteatosis is associated with poor physical fitness in patients undergoing hepatopancreatobiliary surgery Malcolm A West
18.30 – 18.35 FP05 Minimally invasive approach for liver resections in patients with hepatocellular carcinoma and advanced cirrhosis: shifting the paradigm Giammauro Berardi
18.35 – 18.40 FP06 Risk factors of positive resection margin in laparoscopic and open liver surgery for colorectal liver metastases: a new perspective in the perioperative assessment. A European multicentre study Andrea Benedetti Cacciaguerra
E-POSTERS SCREEN 1
16.00 – 17.00 AB09 Outcomes following surgery for liver and/or lung recurrence after liver resection for colorectal liver metastases Elena Theophilidou
AB10 Influence of patient factors and primary tumour factors on survival in patients undergoing curative surgery for colorectal cancer liver metastases Peter Scherman
AB11 The benefit of adjuvant chemotherapy in the subtypes of resected ampullary adenocarcinoma: international propensity score matched study Alma L Moekotte
AB12 Towards personalised use of adjuvant therapy in patients with resected pancreatic cancer after neoadjuvant FOLFIRINOX: pan-European cohort Stijn van Roessel
AB13 Relation between quality of life and survival in pancreatic and periampullary cancer: a multicentre cohort analysis Tara Mackay
AB14 Transatlantic comparison of design, baseline, and outcomes in nationwide audits on pancreatoduodenectomy in the USA, Germany, the Netherlands, and Sweden Tara Mackay
AB15 Ruptured hepatocellular carcinoma: Treatment with microwave ablation may offer additional benefit Maria Baimas-George
SCREEN 2
AB16 International validation and update of the Amsterdam model for prediction of survival after pancreatoduodenectomy for pancreatic cancer Stijn van Roessel
AB17 GRRS (Glucose Relative Risk Score): a novel prognosis predictor of pancreatic ductal adenocarcinoma patients based on 3 cohorts Zijian Zhang
AB18 Conditional survival during follow-up after resection for pancreatic cancer: a population-based study and prediction model Anouk Latenstein
AB19 Treatment and survival of pancreatic cancer recurrence in the Netherlands – a nationwide analysis Lois A. Daamen
AB20 Predicting early disease recurrence for individual patients after resection of pancreatic ductal adenocarcinoma Lois A. Daamen
AB21 The influence of patient age on treatment and survival in locally advanced pancreatic cancer Lilly Brada
AB22 Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer: the multicentre prospective PELICAN-cohort Lilly Brada
FREE PAPERS
TIME No. Presentation Title Presenter
09.20 – 09.25 FP07 A nationwide training program for robotic pancreatoduodenectomy (LAELAPS-3): an analysis of the first 18 trained surgeons and first 226 patients Maurice Zwart
09.25 – 09.30 FP08 Added value of 3D-vision during robotic surgery in biotissue pancreatico- and hepaticojejunostomy (LAEBOT 3D2D): a randomised controlled cross-over trial Maurice Zwart
09.30 – 09.35 FP09 Impact of neoadjuvant therapy in resected pancreatic ductal adenocarcinoma of the pancreatic body and tail on surgical and oncological outcome: a propensity score-matched multicentre study Sanne Lof
E-POSTERS SCREEN 1
16.00 – 17.00 AB23 Novel histology scoring system during normothermic machine perfusion of the liver Luke Matthews
AB24 Perfusate glucose reflects tissue glycogenation during liver perfusion Luke Matthews
AB25 Methaemoglobinaemia can complicate normothermic machine perfusion of human livers Samuel Tingle
AB26 Risk factors associated with anastomotic biliary complications in liver transplantation Emily R Thompson
AB27 Hilar cholangiocarcinoma is a high-risk indication for percutaneous internal biliary drainage – a single centre experience Chris Johnston
AB28 Textbook outcome in patients undergoing laparoscopic versus open liver surgery using a propensity score-based analysis Burak Görgec
AB29 One-or two-stage laparoscopic right hemihepatectomy after portal vein embolisation in patients with initially unresectable colorectal liver metastases: technical aspects and clinical results. Burak Görgec
SCREEN 2
AB30 Quality of life for patients undergoing major hepatectomy appears to be better with minimally invasive surgery Maria Baimas-George
AB31 A randomised controlled trial of laparoscopic and robotic simulation training in gastrointestinal surgery Wasfi Alrawashdeh
AB32 HCC in obese patients: the role of laparoscopic hepatectomy Yoshiya Ishikawa
AB33 The impact of enhanced recovery on open and laparoscopic liver resections Christoph Kummerli
AB34 Laparoscopic versus open right posterior sectionectomy: a multicentre propensity score matched evaluation Nicky van der Heijde
AB35 Laparoscopic duodenopancreatectomy vs open duodenopancreatectomy: learning curve and results Francisco Espin
Back To Top